Liver Cirrhosis Market to Grow at a 4.36% CAGR Forecast to 2020

PUNE, INDIA, July 19, 2016 /EINPresswire.com/ --
About Cirrhosis of the Liver
Cirrhosis of the liver (or liver fibrosis) is a serious condition in which the liver stops functioning properly due to damage and irreversible scarring of the liver tissue. The scarring of the tissue is often caused by long-term exposure to viral infections and toxins such as alcohol. Chronic viral hepatitis and non-alcoholic steatohepatitis can also cause liver cirrhosis. Alcohol-related medications, antiviral medications, and metal chelating agents are used in the treatment of the causes of liver cirrhosis while antibiotics, vitamins, corticosteroids, diuretics, beta-blockers, and laxatives are used for the treatment of the complications of the disease.
Research analysts forecast the global liver cirrhosis therapeutics market to grow at a CAGR of 4.36% during the period 2016-2020.

Complete report details @ https://www.wiseguyreports.com/reports/global-liver-cirrhosis-market-2016-2020-liver-cirrhosis-market-2016-2020

Covered in this report
The report covers the present scenario and the growth prospects of the global liver cirrhosis therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of liver cirrhosis.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Liver Cirrhosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F Hoffman La-Roche
• GlaxoSmithKline
• Gilead Sciences
• Johnson & Johnson
• Merck

Request a sample report @ https://www.wiseguyreports.com/sample-request/global-liver-cirrhosis-market-2016-2020-liver-cirrhosis-market-2016-2020

Other prominent vendors
• Bristol-Myers Squibb
• Conatus Pharmaceuticals
• Gwo Xi Stem Cell Applied Technology
• Instituto Grifols
• Intercept Pharmaceuticals
• NGM Biopharmaceuticals
• Norgine
• Pharmicell
• Salix Pharmaceuticals
• Stempeutics Research
Market driver
• High prevalence of liver cirrhosis
• For a full, detailed list, view our report
Market challenge
• Adverse effects of drugs
• For a full, detailed list, view our report
Market trend
• Use of off-label drugs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/global-liver-cirrhosis-market-2016-2020-liver-cirrhosis-market-2016-2020

Table of content
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
• Etiology
• Symptoms
• Pathophysiology
• Diagnosis
• Epidemiology
• Prevention
• Treatment
• Impact of alcohol consumption on liver cirrhosis
PART 06: Pipeline portfolio
• Information on pipeline candidates
• Clinical trials for liver cirrhosis
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by type of molecule
• Biologics
• Small molecules
PART 09: Market segmentation by types of liver cirrhosis
PART 10: Market segmentation by types of liver cirrhosis treatment
• Medications to treat causes of liver cirrhosis
• Medications to treat complications of liver cirrhosis
PART 11: Geographical segmentation
• Liver cirrhosis medication market in Americas
• Market overview
• Market size and forecast
• Liver cirrhosis medication market in EMEA
• Market overview
• Market size and forecast
• Liver cirrhosis medication market in APAC
• Market overview
• Market size and forecast
PART 12: Market drivers
• High prevalence of liver cirrhosis
• Advances in technology
• High unmet medical needs
• Changes in lifestyle
PART 13: Impact of drivers
PART 14: Market challenges
• Use of alternative therapies
• Adverse effects of drugs
• Poor patient adherence
• Stringent regulatory guidelines
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Rise in public awareness
• Increase in R&D
• Use of off-label drugs
• Patient assistance programs
PART 17: Vendor landscape
• Competitive scenario
• F Hoffmann-La Roche
• GlaxoSmithKline
• Gilead Sciences
• Johnson & Johnson
• Merck
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=466167

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.